TELES AG Informationstechnologien Stock

Equities

TLIK

DE000A289B07

Integrated Telecommunications Services

Market Closed - Xetra 11:36:16 2024-05-03 EDT 5-day change 1st Jan Change
1.08 EUR 0.00% Intraday chart for TELES AG Informationstechnologien +8.54% -19.40%

Financials

Sales 2022 1.92M 2.07M 2.83M Sales 2023 59.28M 63.79M 87.3M Capitalization 8.35M 8.99M 12.3M
Net income 2022 -1M -1.08M -1.47M Net income 2023 -2M -2.15M -2.95M EV / Sales 2022 12.6 x
Net cash position 2022 41.98K 45.18K 61.82K Net Debt 2023 11.1M 11.94M 16.34M EV / Sales 2023 0.33 x
P/E ratio 2022
-14.3 x
P/E ratio 2023
-2.9 x
Employees 51
Yield 2022 *
-
Yield 2023
-
Free-Float 26.91%
More Fundamentals * Assessed data
Dynamic Chart
TELES Aktiengesellschaft Reports Earnings Results for the Full Year Ended December 31, 2023 CI
TELES AG Informationstechnologien Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
TELES AG Informationstechnologien Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
TELES AG Informationstechnologien Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
TELES AG Informationstechnologien Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
TELES AG Informationstechnologien Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
TELES AG Informationstechnologien Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
TELES AG Informationstechnologien Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
TELES AG Informationstechnologien Reports Earnings Results for the Full Year Ended December 31, 2021 CI
TELES AG Informationstechnologien Auditor Raises 'Going Concern' Doubt CI
TELES AG Informationstechnologien Provides Sales Guidance for the Year 2022 CI
TELES AG Informationstechnologien acquired unknown majority stake in EURO RX Arzneimittel GmbH. CI
TELES AG Informationstechnologien acquired an unknown majority stake in Gvl Rechenzentrum Gmbh. CI
TELES AG Informationstechnologien Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Teles Ag Informationstechnologien Reports Earnings Results for the Half Year Ended June 30, 2021 CI
More news
1 week+8.54%
Current month+1.89%
1 month-2.70%
3 months-4.42%
6 months-19.40%
Current year-19.40%
More quotes
1 week
0.95
Extreme 0.95
1.08
1 month
0.95
Extreme 0.95
1.14
Current year
0.95
Extreme 0.95
1.40
1 year
0.95
Extreme 0.95
3.10
3 years
0.95
Extreme 0.95
9.85
5 years
0.33
Extreme 0.332
9.85
10 years
0.18
Extreme 0.184
9.85
More quotes
Managers TitleAgeSince
Chief Executive Officer - 12-31
Members of the board TitleAgeSince
Chairman - 16-10-26
Director/Board Member - 19-08-11
Director/Board Member - 19-08-11
More insiders
Date Price Change Volume
24-05-03 1.08 0.00% 8,221
24-05-02 1.08 +1.89% 8,221
24-04-30 1.06 +2.91% 8,221
24-04-29 1.03 +3.52% 2,419
24-04-26 0.995 -11.16% 2,419

Delayed Quote Xetra, May 03, 2024 at 11:36 am

More quotes
Teles AG is a Germany-based company, formerly known as TELES Informationstechnologien AG. It operates in the pharmaceutical and telecommunications segments. The Company provide services that cover the entire spectrum from analysis of existing infrastructure, requirements and the regulatory framework through investment consulting and development of custom solutions. It helps customers with the configuration, implementation and migration of a new infrastructure solution. The Company's product portfolio comprises Softclients & Mobile Apps that allow users to be reachable via fixed line using computers, tables, mobile phones or office phones. The Company also offers voice application servers and Softswitches for Internet Protocol (IP) networks. In the core business of pharmaceuticals, the focus is on the supply of prescription drugs with a digitized supply chain. Drugs for cancer, autoimmune deficits and combination therapies for personalized medicine are delivered throughout Europe.
More about the company